- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 17)-iFluor® 350 Succinimidyl Ester
Anti-C5 MAb (Clone 17)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS136)
This product is comprised of an Humanized Anti-C5 IgG2-G4-kappa (Clone 17) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 IgG2-G4-kappa (Clone 17)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-APP MAb (Clone 17)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14925)
- Anti-MET MAb (Clone 13)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10634)
- Gavilimomab-iFluor 405 (CAT#: ADC-FL-200)
- Anti-CA9 MAb (Clone 2)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS396)
- Anti-NGF MAb (Clone 9)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS6052)
- Anti-CD22 MAb (Clone 20)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11304)
- Anti-FUT3 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS434)
- Anti-PDCD1 MAb (Clone 30)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1476)
- Anti-ERBB3 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4829)
- Anti-MYL MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16137)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS136. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-739 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-729 | Anti-C5 (Eculizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-732 | Anti-C5 (Eculizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-738 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-731 | Anti-C5 (Eculizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
